Literature DB >> 21217605

Insights into the pathogenesis of XXY phenotype from comparison of the clinical syndrome with an experimental XXY mouse model.

Yan-he Lue1, Christina Wang, Peter Y Liu, Krista Erkilla, Ronald S Swerdloff.   

Abstract

Klinefelter syndrome (47, XXY male) is the most common sex chromosome disorder in men. To study the underlying mechanisms of XXY phenotypes and design specific and novel therapeutic regimens for KS men, an experimental mouse model (41, XXY) was established. This manuscript compares the phenotypes of XXY men and mice and discusses the possible contributions of low androgen levels and extra X chromosome genes to the XXY phenotypes. The phenotypic similarities between XXY mouse and men suggest that the common genes that escape the X inactivation between XXY mouse and men may be responsible for the clinical manifestations in men with Klinefelter syndrome.

Entities:  

Mesh:

Year:  2010        PMID: 21217605

Source DB:  PubMed          Journal:  Pediatr Endocrinol Rev        ISSN: 1565-4753


  4 in total

Review 1.  Sexual differentiation of brain and other tissues: Five questions for the next 50 years.

Authors:  Arthur P Arnold
Journal:  Horm Behav       Date:  2020-01-31       Impact factor: 3.587

Review 2.  Testis Development and Fertility Potential in Boys with Klinefelter Syndrome.

Authors:  Shanlee M Davis; Alan D Rogol; Judith L Ross
Journal:  Endocrinol Metab Clin North Am       Date:  2015-09-28       Impact factor: 4.741

Review 3.  The importance of having two X chromosomes.

Authors:  Arthur P Arnold; Karen Reue; Mansoureh Eghbali; Eric Vilain; Xuqi Chen; Negar Ghahramani; Yuichiro Itoh; Jingyuan Li; Jenny C Link; Tuck Ngun; Shayna M Williams-Burris
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2016-02-01       Impact factor: 6.237

Review 4.  A primer on the use of mouse models for identifying direct sex chromosome effects that cause sex differences in non-gonadal tissues.

Authors:  Paul S Burgoyne; Arthur P Arnold
Journal:  Biol Sex Differ       Date:  2016-12-13       Impact factor: 5.027

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.